CSTL

Castle Biosciences, Inc. NASDAQ Listed Jul 25, 2019

Healthcare ·Medical - Diagnostics & Research ·US · castlebiosciences.com

$24.75

After hrs $24.75 +0.00%

Mkt Cap $749.8M

52w Low $14.59 34.2% of range 52w High $44.28

50d MA $25.64 200d MA $28.50

P/E (TTM) -29.9x

EV/EBITDA 92.4x

P/B 1.5x

Debt/Equity 0.1x

ROE -5.1%

P/FCF 39.8x

RSI (14) —

ATR (14) —

Beta 1.19

50d MA $25.64

200d MA $28.50

Avg Volume 375.4K

About

Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test t…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 26, 2026	AMC	-0.23	-0.08	+65.2%	31.88	-6.3%	-7.2%	-12.2%	-13.5%	-11.6%	-12.5%	—
Nov 3, 2025	AMC	-0.34	-0.02	+94.1%	25.99	+3.6%	+21.7%	+29.2%	+29.1%	+27.1%	+33.7%	—
Aug 4, 2025	AMC	-0.51	0.15	+129.4%	15.32	+29.6%	+32.8%	+29.0%	+28.3%	+26.4%	+25.1%	—
May 5, 2025	AMC	-0.08	-0.20	-150.0%	18.75	-13.5%	-11.4%	-9.1%	-8.2%	-10.5%	-9.1%	—
Feb 27, 2025	AMC	-0.04	0.32	+900.0%	25.28	+2.8%	-14.2%	-15.9%	-12.1%	-15.7%	-18.6%	—
Nov 4, 2024	AMC	-0.06	0.08	+233.3%	33.64	+6.5%	-7.4%	-2.9%	-1.0%	-1.0%	+0.4%	—
Aug 5, 2024	AMC	-0.27	0.31	+214.8%	21.85	+20.1%	+14.0%	+22.7%	+27.4%	+22.8%	+22.4%	—
May 2, 2024	AMC	-0.37	-0.09	+75.7%	22.84	+2.9%	+6.5%	+6.9%	+4.2%	+3.1%	+6.9%	—
Feb 28, 2024	AMC	-0.84	-0.10	+88.1%	24.39	+1.9%	-26.0%	-18.2%	-13.0%	-8.5%	-12.0%	—
Nov 2, 2023	AMC	-0.92	-0.26	+71.7%	16.65	+8.1%	+8.0%	+8.5%	+8.1%	+7.9%	+2.9%	—
Aug 2, 2023	AMC	-1.01	-0.70	+30.7%	16.79	+11.2%	+11.8%	+10.2%	+6.6%	+5.5%	+5.3%	—
May 3, 2023	AMC	-0.80	-1.10	-37.5%	22.91	-4.3%	-3.9%	-2.9%	-1.2%	-1.1%	+1.3%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 20	Canaccord Genuity	Maintains	Buy → Buy	—	$25.05	$24.67	-1.5%	+0.4%	-1.9%	+0.2%	-5.4%	-2.4%
Feb 27	Baird	Maintains	Outperform → Outperform	—	$31.88	$29.87	-6.3%	-7.2%	-12.2%	-13.5%	-11.6%	-12.5%
Jan 26	Guggenheim	Maintains	Buy → Buy	—	$42.24	$42.25	+0.0%	+1.9%	+1.4%	-6.5%	-7.3%	-6.7%
Jan 12	Lake Street	Maintains	Buy → Buy	—	$39.34	$40.80	+3.7%	+0.8%	+0.8%	+3.6%	+3.6%	+1.7%
Jan 5	Guggenheim	Maintains	Buy → Buy	—	$38.54	$38.48	-0.2%	+1.2%	+4.0%	+5.4%	+3.5%	+2.1%
Dec 22	Canaccord Genuity	Maintains	Buy → Buy	—	$39.44	$40.00	+1.4%	+4.9%	+1.9%	+1.6%	-0.1%	-0.4%
Dec 12	BTIG	Maintains	Buy → Buy	—	$37.97	$38.93	+2.5%	+1.7%	+2.4%	+2.8%	+4.5%	+4.3%
Nov 5	BTIG	Maintains	Buy → Buy	—	$31.63	$31.56	-0.2%	+6.1%	+6.1%	+4.5%	+9.8%	+10.6%
Nov 4	Baird	Maintains	Outperform → Outperform	—	$25.99	$26.93	+3.6%	+21.7%	+29.2%	+29.1%	+27.1%	+33.7%
Sep 9	Canaccord Genuity	Maintains	Buy → Buy	—	$24.06	$24.24	+0.7%	+2.5%	-4.7%	-5.4%	-11.0%	-10.1%
May 21	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$16.50	$16.34	-1.0%	-2.9%	-3.7%	-2.4%	-4.2%	-1.6%
May 6	Lake Street	Maintains	Buy → Buy	—	$18.75	$16.21	-13.5%	-11.4%	-9.1%	-8.2%	-10.5%	-9.1%
May 6	Canaccord Genuity	Maintains	Buy → Buy	—	$18.75	$16.21	-13.5%	-11.4%	-9.1%	-8.2%	-10.5%	-9.1%
Feb 28	Baird	Maintains	Outperform → Outperform	—	$25.28	$26.00	+2.8%	-14.2%	-15.9%	-12.1%	-15.7%	-18.6%
Jan 2	Stephens & Co.	Maintains	Overweight → Overweight	—	$26.65	$26.82	+0.6%	+5.2%	+7.4%	+10.2%	+20.7%	+22.8%
Nov 6	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$31.15	$32.90	+5.6%	+4.8%	+6.9%	+6.9%	+8.4%	+5.2%
Nov 5	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$33.64	$35.84	+6.5%	-7.4%	-2.9%	-1.0%	-1.0%	+0.4%
Nov 5	Baird	Maintains	Outperform → Outperform	—	$33.64	$35.84	+6.5%	-7.4%	-2.9%	-1.0%	-1.0%	+0.4%
Nov 5	Lake Street	Maintains	Buy → Buy	—	$33.64	$35.84	+6.5%	-7.4%	-2.9%	-1.0%	-1.0%	+0.4%
Oct 29	Canaccord Genuity	Maintains	Buy → Buy	—	$32.40	$32.48	+0.2%	+4.3%	+6.6%	+7.0%	+2.3%	+3.8%
Oct 14	BTIG	Maintains	Buy → Buy	—	$31.31	$31.94	+2.0%	+9.4%	+6.9%	+7.9%	+5.6%	+4.2%
Aug 6	Baird	Maintains	Outperform → Outperform	—	$21.85	$26.25	+20.1%	+14.0%	+22.7%	+27.4%	+22.8%	+22.4%
Aug 6	Stephens & Co.	Maintains	Overweight → Overweight	—	$21.85	$26.25	+20.1%	+14.0%	+22.7%	+27.4%	+22.8%	+22.4%
Jul 5	Baird	Maintains	Outperform → Outperform	—	$21.25	$19.13	-10.0%	-18.1%	-15.5%	-16.0%	-17.7%	-13.0%
May 3	Baird	Maintains	Outperform → Outperform	—	$22.84	$23.50	+2.9%	+6.5%	+6.9%	+4.2%	+3.1%	+6.9%
Mar 1	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$18.06	$18.67	+3.4%	+10.4%	+17.6%	+23.5%	+18.8%	+14.9%
Mar 1	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$18.06	$18.67	+3.4%	+10.4%	+17.6%	+23.5%	+18.8%	+14.9%
Aug 4	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$18.77	$18.84	+0.4%	-1.4%	-4.7%	-5.6%	-5.8%	-6.8%
Jul 7	Lake Street	Maintains	Buy → Buy	—	$13.28	$20.00	+50.6%	+52.9%	+49.4%	+48.2%	+35.0%	+22.0%
Jul 6	Stephens & Co.	Maintains	Overweight → Overweight	—	$13.70	$13.39	-2.3%	-3.1%	+48.2%	+44.8%	+43.6%	+30.9%
Jun 15	BTIG	Maintains	Buy → Buy	—	$13.67	$13.55	-0.9%	-2.0%	-3.6%	-3.1%	-4.7%	-3.1%
Jun 7	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$14.72	$15.13	+2.8%	+1.3%	-2.6%	-0.4%	+0.1%	-1.8%
Jun 6	Canaccord Genuity	Maintains	Buy → Buy	—	$11.66	$11.84	+1.5%	+26.2%	+27.9%	+22.9%	+25.7%	+26.3%
Jun 5	Lake Street	Maintains	Buy → Buy	—	$22.73	$17.70	-22.1%	-48.7%	-35.2%	-34.4%	-37.0%	-35.5%
Jun 5	SVB Securities	Maintains	Outperform → Outperform	—	$22.73	$17.70	-22.1%	-48.7%	-35.2%	-34.4%	-37.0%	-35.5%
Jun 5	Baird	Maintains	Outperform → Outperform	—	$22.73	$17.70	-22.1%	-48.7%	-35.2%	-34.4%	-37.0%	-35.5%
May 8	Stephens & Co.	Maintains	Overweight → Overweight	—	$22.25	$22.04	-0.9%	+1.8%	+1.8%	+4.3%	+2.0%	+2.8%
May 5	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$22.01	$22.46	+2.0%	+1.1%	+2.9%	+2.9%	+5.4%	+3.1%
May 4	Stephens & Co.	Maintains	Overweight → Overweight	—	$22.91	$21.93	-4.3%	-3.9%	-2.9%	-1.2%	-1.1%	+1.3%
May 4	Baird	Maintains	Outperform → Outperform	—	$22.91	$21.93	-4.3%	-3.9%	-2.9%	-1.2%	-1.1%	+1.3%
Mar 2	Stephens & Co.	Maintains	Overweight → Overweight	—	$22.86	$22.50	-1.6%	+3.4%	+8.0%	+6.2%	-1.1%	-5.1%
Mar 1	Baird	Maintains	Outperform → Outperform	—	$25.18	$25.10	-0.3%	-9.2%	-6.1%	-2.0%	-3.6%	-10.2%
Jan 5	Scotiabank	Maintains	Sector Outperform → Outperform	—	$23.14	$24.23	+4.7%	-1.3%	-1.5%	+1.0%	+6.9%	+10.0%
Nov 3	Baird	Maintains	Outperform → Outperform	—	$24.77	$25.93	+4.7%	-2.0%	-11.4%	-20.5%	-18.8%	-27.0%
Aug 9	Baird	Maintains	Outperform → Outperform	—	$28.48	$32.50	+14.1%	+7.6%	+20.5%	+20.1%	+19.2%	+17.6%
Aug 9	SVB Leerink	Maintains	Market Outperform → Market Outperform	—	$28.48	$32.50	+14.1%	+7.6%	+20.5%	+20.1%	+19.2%	+17.6%
May 11	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$20.28	$19.87	-2.0%	-10.7%	-6.5%	-2.8%	-3.9%	-0.7%
May 10	Baird	Maintains	Outperform → Outperform	—	$19.17	$19.36	+1.0%	+5.8%	-5.6%	-1.0%	+2.8%	+1.6%
May 10	SVB Leerink	Maintains	Outperform → Outperform	—	$19.17	$19.36	+1.0%	+5.8%	-5.6%	-1.0%	+2.8%	+1.6%
Apr 5	Canaccord Genuity	Maintains	Buy → Buy	—	$45.99	$45.99	+0.0%	-16.5%	-21.3%	-24.0%	-28.8%	-32.8%

Recent Filings

8-K · 7.01 ! Medium

Castle Biosciences, Inc. -- 8-K 7.01: Regulation FD Disclosure

Castle Biosciences disclosed a slide presentation for investor communications, indicating management plans to use this material in future meetings to discuss company strategy and performance.

Feb 26

Data updated apr 25, 2026 3:35am · Source: massive.com